Shire Looks To Quash Mylan's Generic Colitis Drug
Irish pharmaceutical company Shire Development LLC on Monday hit Mylan Pharmaceuticals Inc. with a patent suit in Florida federal court, launching another attack against a generic-drug maker attempting to produce its...To view the full article, register now.
Already a subscriber? Click here to view full article